A Phase 2, Single-Center, Open-Label, Pharmacodynamic Clinical Trial to Evaluate the Effect of Technosphere Insulin Inhalation Powder on Postprandial Glucose Levels in Subjects With Type 1 and Type 2 Diabetes Mellitus Ingesting Meals With Varied Carbohydrate Content.
Phase of Trial: Phase II
Latest Information Update: 28 Oct 2014
At a glance
- Drugs Insulin lispro (Primary) ; Insulin
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors MannKind Corporation
- 20 Oct 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 13 Jul 2011 Actual end date changed from Feb 2011 to May 2011 as reported by ClinicalTrials.gov.
- 10 Mar 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.